Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7 – 10 July 2025

Vaccine to be used only when there is a significant chikungunya risk and after careful consideration of the benefits and risks EMA’s safety committee (PRAC) has completed its…, Agenda Agenda of the PRAC meeting 7-10 July 2025DraftReference Number: EMA/PRAC/202278/2025 English (EN…, PRAC statistics: July 2025 , , Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…